B A S E C A R E

Our mission

Help more family have a healthy baby

We focus on the application and research of gene technology in the field of reproductive health, to help infertility patients "can give birth", let patients with family genetic diseases "eugenics", for the country and national eugenics contributions.

Our Vision

Being a leading reproductive brand

Provide comprehensive genetic testing solution for clinical institutions

Established in 2010, Basecare is committed to the research and development and clinical application of high-throughput sequencing technology in the field of reproductive health. It is a leading talent enterprise in Suzhou industrial park with 1500 square meters production center, 3000 square meters research center and 4000 square meters testing center.

Since its establishment, Basecare has been adhering to the concept of "doing compliance products" and adhering to the path of compliance research, development, and registration. In 2019, we completed large scale clinical trial for PGS kit. In 2020, the product was approved by the state food and drug administration, marking the entry of China’s third generation IVF technology in the licensed era of medical device supervision.

In the future, we will continue to focus on the research and development of good products in the field of reproduction, through technological innovation, change their lives, so that more people can benefit from the progress of gene technology, and ultimately contribute to the country and nation's eugenics.

Development history

In wind and rain,
we march forward step with step!

From the company's start-up to the clinical application, and then to the approval of PGS products on the market,
the development path of the decade is full of hardships and sweat Water, but more full of passion and hope.
Thanksgiving Basecare people, carefully polished products, good service; We are grateful to those who have
given us advice and help, and we will continue to give back to the society with the best products and services.

The PGS kit officially obtained the world's first registration certificate of Class III medical devices, and the PGS officially entered the era of certification.

2020
March

The company was founded to build a big data biological information analysis platform, and began to provide scientific research services based on the next generation sequencing technology.

2010
March

Set up joint laboratory with Life science to develop the first NIPT detection kit based on second generation sequencer.

2013
June

Cooperated with Dana gene to complete the registration of second generation sequencer and NIP kit.

2014
May

Approval of national innovative medical devices, which raised the level of standardization of third generation IVF industry.

2015
April

Established productive & genetic clinical research center with Thermo fisher.

2016
September

Participated in the development of PGS quality control evaluation guidelines, to fill the gap of China's third generation IVF quality control technical standards.

2017
October

Obtained the GMP workshop production qualification, has the large-scale medical equipment production capacity, lays the solid foundation for the industrialization.

2018
August

Our clinical trial for PGS kit is the world’s largest clinical trial with the largest amount of data.

2019
November

The PGS kit officially obtained the world's first registration certificate of Class III medical devices, and the PGS officially entered the era of certification.

2020
March